Patents by Inventor Timothy Chan

Timothy Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11955213
    Abstract: In clinical documentation, mere documentation of a condition in a patient's records may not be enough. To be considered sufficiently documented, the patient's record needs to show that no documentation drop-offs (DDOs) have occurred over the course of the patient's stay. However, DDOs can be extremely difficult to detect. To solve this problem, the invention trains time-sensitive deep learning (DL) models on a per condition basis using actual and/or synthetic patient data. Utilizing an ontology, grouped concepts can be generated on the fly from real-time hospital data and used to generate time-series data that can then be analyzed by trained time-sensitive DL models to determine whether a DDO for a condition has occurred during the stay. Non-time-sensitive models can be used to detect all the conditions documented during the stay. Outcomes from the models can be compared to determine whether to notify a user that a DDO has occurred.
    Type: Grant
    Filed: February 13, 2023
    Date of Patent: April 9, 2024
    Assignee: IODINE SOFTWARE, LLC
    Inventors: Jonathan Matthews, W. Lance Eason, William Chan, Michael Kadyan, Frances Elizabeth Jurcak, Timothy Paul Harper
  • Patent number: 11944606
    Abstract: Azaindole compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the azaindole compounds.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: April 2, 2024
    Assignee: Genentech, Inc.
    Inventors: Timothy Heffron, Sushant Malhotra, BinQing Wei, Bryan Chan, Lewis Gazzard, Emanuela Gancia, Michael Lainchbury, Andrew Madin, Eileen Seward, Yonghan Hu
  • Publication number: 20240087738
    Abstract: A telepresence robot may include a drive system, a control system, an imaging system, and a mapping module. The mapping module may access a plan view map of an area and tags associated with the area. In various embodiments, each tag may include tag coordinates and tag information, which may include a tag annotation. A tag identification system may identify tags within a predetermined range of the current position and the control system may execute an action based on an identified tag whose tag information comprises a telepresence robot action modifier. The telepresence robot may rotate an upper portion independent from a lower portion. A remote terminal may allow an operator to control the telepresence robot using any combination of control methods, including by selecting a destination in a live video feed, by selecting a destination on a plan view map, or by using a joystick or other peripheral device.
    Type: Application
    Filed: November 17, 2023
    Publication date: March 14, 2024
    Inventors: Yulun Wang, Charles S. Jordan, Tim Wright, Michael Chan, Marco Pinter, Kevin Hanrahan, Daniel Sanchez, James Ballantyne, Cody Herzog, Blair Whitney, Fuji Lai, Kelton Temby, Eben Christopher Rauhut, Justin H. Kearns, Cheuk Wah Wong, Timothy Sturtevant Farlow
  • Publication number: 20230252087
    Abstract: A data processing system implements receiving a request for user-centric topic recommendations from a computing device of a user in response to a user input in an application indicating that the user is attempting to assign a tag to a first content item in the application; obtaining a first set of user-centric topic recommendations from a first topic datastore based on a relevance ranking assigned to each of the topic recommendations; providing the first set of user-centric topic recommendations to the computing device; causing the computing device to display the first set of user-centric topic recommendations; receiving one or more second requests for user-centric topic recommendations; obtaining one or more second sets of user-centric topic recommendations from the first topic datastore based on the query string and the relevance ranking; and causing the computing device of the user to display the one or more second sets of user-centric topic recommendations.
    Type: Application
    Filed: February 7, 2022
    Publication date: August 10, 2023
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: David Timothy CHAN, Dmitriy MEYERZON, Sebastian Johannes BLOHM, Anita RAJAN, Ravi Kumar BIKKULA
  • Patent number: 11704371
    Abstract: A data processing system implements receiving a request for user-centric topic recommendations from a computing device of a user in response to a user input in an application indicating that the user is attempting to assign a tag to a first content item in the application; obtaining a first set of user-centric topic recommendations from a first topic datastore based on a relevance ranking assigned to each of the topic recommendations; providing the first set of user-centric topic recommendations to the computing device; causing the computing device to display the first set of user-centric topic recommendations; receiving one or more second requests for user-centric topic recommendations; obtaining one or more second sets of user-centric topic recommendations from the first topic datastore based on the query string and the relevance ranking; and causing the computing device of the user to display the one or more second sets of user-centric topic recommendations.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: July 18, 2023
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: David Timothy Chan, Dmitriy Meyerzon, Sebastian Johannes Blohm, Anita Rajan, Ravi Kumar Bikkula
  • Publication number: 20230126519
    Abstract: Systems and methods are provided for relevance-based media content discovery. Relevance scores for segments of a media asset are calculated based on a time amount that at least one viewer has viewed the segments of the media asset. Segments are then chosen for display based on the relevance score. Users may select segments based on representative images of the segments.
    Type: Application
    Filed: December 22, 2022
    Publication date: April 27, 2023
    Inventors: John Hinman, Ray DeRenzo, Timothy Chan, Allen Billings, Stephen Coney, David Brubeck
  • Publication number: 20230113598
    Abstract: The present invention provides compounds useful as inhibitors of PDK1. The present invention also provides compositions thereof, and methods of treating PDK1-mediated diseases.
    Type: Application
    Filed: July 21, 2022
    Publication date: April 13, 2023
    Inventors: Joseph ARNDT, Timothy Chan, Kevin Guckian, Gnanasambandam Kumaravel, Wen-Cheng Lee, Edward Yin-Shiang Lin, Daniel Scott, Lihong Sun, Jermaine Thomas, Kurt Van Vloten, Deping Wang, Lei Zhang, Daniel Erlanson
  • Publication number: 20230002490
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Application
    Filed: May 16, 2022
    Publication date: January 5, 2023
    Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: Timothy A. CHAN, Nadeem RIAZ
  • Publication number: 20220389102
    Abstract: Molecular determinants of cancer response to immunotherapy are described.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 8, 2022
    Inventors: Timothy A. Chan, Diego Chowell Puente, Chirag Krishna, Tobias Leander Lenz, Federica Pierini
  • Publication number: 20220340663
    Abstract: The present invention encompasses the discovery that the likelihood of a favorable response to cancer immunotherapy for a wide range of different cancers can be predicted through definition of a tumor mutational load threshold for the tumor (and/or the relevant immunotherapy).
    Type: Application
    Filed: November 29, 2021
    Publication date: October 27, 2022
    Inventors: Timothy A. Chan, Diego Chowell Puente, Robert M. Samstein, Luc Morris
  • Patent number: 11427561
    Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production. Formula (I) The compounds are IRAK-4 inhibitors useful for treating an inflammatory disease, an autoimmune disease, cancer, a cardiovascular disease, a disease of the central nervous system, a disease of the skin, an ophthalmic disease and condition, and a bone disease.
    Type: Grant
    Filed: January 18, 2017
    Date of Patent: August 30, 2022
    Assignee: BIOGEN MA INC.
    Inventors: Timothy Chan, Kevin M. Guckian, Tracy Jenkins, Jermaine Thomas, Jeffrey Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph P. Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield, Nathan Genung
  • Patent number: 11332530
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: May 17, 2022
    Assignee: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: Timothy A. Chan, Nadeem Riaz
  • Patent number: 11230599
    Abstract: The present invention encompasses the discovery that the likelihood of a favorable response to cancer immunotherapy for a wide range of different cancers can be predicted through definition of a tumor mutational load threshold for the tumor (and/or the relevant immunotherapy).
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: January 25, 2022
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Timothy A. Chan, Diego Chowell Puente, Robert M. Samstein, Luc Morris
  • Publication number: 20210308241
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Application
    Filed: March 15, 2021
    Publication date: October 7, 2021
    Inventors: Timothy A. Chan, Naiyer A. Rizvi, Matthew D. Hellmann
  • Publication number: 20210295742
    Abstract: Exemplary embodiments include systems and methods for simulating a medical procedure. The simulator may approximate a portion of the body including the vasculature for providing simulation of accessing the vasculature in the medical procedure. The simulator may therefore include any combination of pump(s), conduit(s), reservoir(s), valve(s), body material, coverings, etc.
    Type: Application
    Filed: March 22, 2021
    Publication date: September 23, 2021
    Inventors: Timothy Chan, Jason Kiyoshi Chan
  • Publication number: 20210266642
    Abstract: Mechanisms are provided for character-based and image-based media content search and discovery. Character images or entity images are mapped to corresponding media content. Selection of an image or a portion of an image may trigger or search for corresponding media content or begin playback of relevant media content. Character images or entity images need not correspond to a primary program character or object but may correspond to minor characters or tangential entities depicted periodically on particular programs.
    Type: Application
    Filed: September 28, 2020
    Publication date: August 26, 2021
    Inventors: John Hinman, Ray DeRenzo, Timothy Chan, Allen Billings, Stephen Coney, David Brubeck
  • Publication number: 20210188809
    Abstract: Provided are compounds of Formula I, or pharmaceutically acceptable salts thereof, and methods for their use and production. Formula (I) The compounds are IRAK-4 inhibitors useful for treating an inflammatory disease, an autoimmune disease, cancer, a cardiovascular disease, a disease of the central nervous system, a disease of the skin, an ophthalmic disease and condition, and a bone disease.
    Type: Application
    Filed: January 18, 2017
    Publication date: June 24, 2021
    Inventors: Timothy Chan, Kevin Guckian, Tracy Jenkins, Jermaine Thomas, Jeffrey Vessels, Gnanasambandam Kumaravel, Robert Meissner, Joseph P. Lyssikatos, Brian Lucas, Irina Leaf, Jeremy Duffield, Nathan Genung
  • Patent number: 10993998
    Abstract: Molecular determinants of cancer response to immunotherapy are described, as are systems and tools for identifying and/or characterizing cancers likely to respond to immunotherapy.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: May 4, 2021
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: Timothy A. Chan, Naiyer A. Rizvi, Matthew D. Hellmann
  • Patent number: 10812863
    Abstract: Mechanisms are provided for character-based and image-based media content search and discovery. Character images or entity images are mapped to corresponding media content. Selection of an image or a portion of an image may trigger or search for corresponding media content or begin playback of relevant media content. Character images or entity images need not correspond to a primary program character or object but may correspond to minor characters or tangential entities depicted periodically on particular programs.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: October 20, 2020
    Assignee: MobiTV, Inc.
    Inventors: John Hinman, Ray DeRenzo, Timothy Chan, Allen Billings, Stephen Coney, David Brubeck
  • Publication number: 20200232040
    Abstract: Systems and methods for determining the likely responsiveness of a human cancer subject to a checkpoint blockade immunotherapy regimen are provided. Sequencing reads are obtained from samples from the subject representative of the cancer. A human leukocyte antigen type and a plurality of clones is determined from the sequencing reads. For each clone, an initial frequency X? in the one or more samples is determined and a corresponding clone fitness score of the clone is computed, thereby computing clone fitness scores. Each such fitness score is computed by identifying neoantigens in the respective clone, computing a recognition potential for each neoantigen, and determining the corresponding clone fitness score of the respective clone as an aggregate of these recognition potentials. A total fitness, quantifying the likely responsiveness of the subject to the regimen, is computed by summing the clone fitness scores across the plurality of clones.
    Type: Application
    Filed: January 18, 2018
    Publication date: July 23, 2020
    Inventors: Marta Luksza, Vinod P. Balachandran, Arnold J. Levin, Jedd D. Wolchok, Taha Merghoub, Steven D. Leach, Timothy A. Chan, Benjamin D. Greenbaum, Michael Laessig